Fenwick & West LLP advised Bicycle Health on the deal. Bicycle Health, a leading virtual care provider of evidence-based treatment for opioid use disorder, announced its $50 […]
Bicycle Health’s $50 Million Series B Financing
Overair’s $145 Million Financing
Fenwick & West advised Overair on the deal. Overair, a California-based electric vertical takeoff and landing (eVTOL) vehicle startup, announced its $145 million financing. The round was […]
Bolt’s Acquisition of Wyre
Fenwick represented Wyre on the deal. Wyre, a cryptocurrency infrastructure provider, announced its agreement to be acquired by Bolt, an online checkout experience platform. The acquisition, which […]
Deepcell’s $73 Million Series B Financing
Fenwick advised Deepcell on the deal. Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translational research, announced its $73 million […]
Silver Lake’s $200 Million Investment in Alchemy
Simpson Thacher represented Silver Lake on the deal while Fenwick represented Alchemy. Silver Lake announced their role as co-lead investor in a $200 million financing round in […]
Nurx’s Merger with Thirty Madison
Fenwick & West and Jones Day advised Nurx on the deal while Cooley and Foley & Lardner LLP advised Thirty Madison. Nurx, a female-focused digital healthcare […]
Calm’s Acquisition of Ripple Health
Fenwick & West advised Calm on the deal while O’Melveny represented Ripple Health Group. Calm, a mental wellness brand with an app for sleep, meditation and […]
Vista Equity Partners’ Investment in TigerConnect
Fenwick & West advised TigerConnect on the deal. TigerConnect, maker of a powerful healthcare software collaboration suite, announced its strategic growth investment from Vista Equity Partners, a […]
Merit’s $50 Million Series B Financing
Fenwick & West advised Merit on the deal. Merit, a verified identity platform, announced its $50 million Series B financing. Rose Park Advisors led the financing round […]
DexCare’s $50 Million Series B Financing
Fenwick & West advised DexCare on the deal. DexCare, a data-driven intelligence company focused on healthcare access, announced its $50 million Series B financing. The round was […]
Freenome’s $300 Million Series D Financing
Fenwick & West advised Freenome on the deal. Freenome, a privately held biotechnology company, announced its $300million Series D financing. The round was led by investors Perceptive […]
Alchemy’s $250 Million Series C Financing
Fenwick & West LLP advised Alchemy on the deal. Alchemy, a leading developer platform for blockchain and Web3, announced its $250 million Series C financing. The investment […]